Tenon Medical Inc. said it has regained compliance with Nasdaq’s minimum bid price requirement after completing a 1-for-35 reverse stock split.
The Nasdaq Stock Market’s Listing Qualifications staff had notified Tenon Medical on February 25, 2026, that its shares had traded below $1.00 per share for 30 consecutive business days, triggering a deficiency under Nasdaq Listing Rule 5550(a)(2). The company executed the reverse split on August 10, 2026, which restored its share price above the $1.00 threshold. From August 10 through August 21, Tenon Medical’s closing bid price consistently met or exceeded the requirement.
Nasdaq issued a compliance confirmation notice on August 24, 2026, indicating that Tenon Medical had satisfied the minimum bid price rule. The company, incorporated in Delaware in 2012, develops medical devices for treating sacro-pelvic disorders and currently markets two systems for sacroiliac joint treatment.
